A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia

The main purpose of this study is to compare two types of care - standard leukemia oncology
care and standard leukemia oncology care with collaborative involvement of palliative care
clinicians to see which is better for improving the experience of patients and families with
AML undergoing treatment.

The investigators aim to find out whether introducing patients and families undergoing AML
treatment to the palliative care team that specializes in symptom management can improve the
physical and psychological symptoms that patients and families experience during their
hospitalizations for their leukemia care as well as enhance the quality of patients' end of
life care.

Inclusion Criteria:

- Hospitalized patients with high-risk AML, defined as:

- Newly diagnosed patients with AML ≥ 60 years of age

- Newly diagnosed AML with antecedent hematologic disorder

- Newly diagnosed therapy-related AML

- Relapsed AML

- Primary refractory AML

Exclusion Criteria:

- Patients already receiving palliative care

- Major psychiatric illness or comorbid conditions prohibiting compliance with study
procedures.

- A diagnosis of acute promyelocytic leukemia (APML)